583.30
Schlusskurs vom Vortag:
$585.01
Offen:
$590.45
24-Stunden-Volumen:
57,172
Relative Volume:
0.15
Marktkapitalisierung:
$16.30B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$460.40M
KGV:
36.69
EPS:
15.8963
Netto-Cashflow:
$711.00M
1W Leistung:
+1.18%
1M Leistung:
+6.88%
6M Leistung:
+7.72%
1J Leistung:
+36.17%
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings Inc
|
583.93 | 16.45B | 2.68B | 460.40M | 711.00M | 15.90 |
|
TMO
Thermo Fisher Scientific Inc
|
586.95 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
203.74 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
588.99 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
320.42 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
144.78 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-18 | Hochstufung | TD Cowen | Sell → Hold |
| 2026-02-13 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-02 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Medpace (NASDAQ: MEDP) holder to sell 4,000 shares after earlier 11,000-sale - Stock Titan
Medpace Holdings, Inc. Stock 12‑Month Price Target Raised to $601.09, Implies 2% Upside - TradingView
Form 144 Medpace Holdings For: 28 July By Investing.com - Investing.com India
Medpace Holdings, Inc. SEC Filing (Jul 27, 2026) - Stock Titan
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP) - Yahoo Finance UK
Medpace Holdings revenue up 17.2% to USD 707.3M in Q2 2026 - Medical Buyer
Medpace Holdings Inc (MEDP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Medpace Holdings Inc (MEDP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Medpace Holdings Inc (MEDP) Income Statement - TradingKey
Medpace Holdings, Inc. Revenue Breakdown – MIL:1MEDP - TradingView
Medpace Stock: Cancellations Are Normalizing (NASDAQ:MEDP) - Seeking Alpha
Why Medpace Holdings (MEDP) Is Up 11.8% After Raising 2026 Guidance And Expanding Backlog - Yahoo Finance
Medpace Holdings Is Maintained at Hold by TD Cowen - Moomoo
BMO raises Medpace stock price target to $600 on strong demand - Investing.com UK
TD Cowen raises Medpace stock price target on bookings outlook By Investing.com - Investing.com South Africa
MEDPACE HOLDINGS INC : TD COWEN RAISES TARGET PRICE TO $492 FROM $419 - Bitget
Medpace Holdings Price Target Raised to $492.00/Share From $419.00 by TD Cowen - Moomoo
Medpace Holdings Inc (MEDP) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Medpace Holdings Inc (MEDP) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Medpace Holdings Inc (MEDP) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
BMO raises Medpace stock price target to $600 on strong demand By Investing.com - Investing.com South Africa
Medpace's Bookings Recovery, Normalization of Cancellations Support Growth, RBC Says - Moomoo
MEDPACE HOLDINGS INC : RBC RAISES TARGET PRICE TO $692 FROM $484 - Bitget
Medpace Holdings Inc (MEDP) Earnings Dates, Call Summary & Reports - TipRanks
MEDPACE HOLDINGS INC : BMO RAISES TARGET PRICE TO $600 FROM $400 - Bitget
TD Cowen raises Medpace stock price target on bookings outlook - Investing.com
Medpace Holdings, Inc. (MEDP) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Truist Raises Price Target on Medpace Holdings to $609 From $462, Keeps Hold Rating - marketscreener.com
RBC Raises Price Target on Medpace Holdings to $692 From $484, Keeps Outperform Rating - marketscreener.com
MEDP|Medpace Holdings Inc|Price:593.430|Chg%:-7.950 - TradingKey
Medpace Holdings Inc (MEDP) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Medpace Holdings Inc (MEDP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo Finance
Medpace Earnings: Stronger Bookings and Easing Cancellations Support Improved Near-Term Outlook - Morningstar
Narrow-Moat Medpace's Stronger Bookings and Easing Cancellations Support Improved Near-Term Outlook - Morningstar
Medpace Holdings, Inc. Stock 12‑Month Price Target Raised to $508.55, Implies 4% Downside - TradingView
Medpace Holdings Inc (MEDP) Shares Surge 14.7% -- What GF Score of 93 Tells Investors - GuruFocus
Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: St - GuruFocus
Form 144 Medpace Holdings For: 23 July By Investing.com - Investing.com Nigeria
Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ... - Yahoo Finance
Medpace Holdings, Inc. SEC Filing (Jul 23, 2026) - Stock Titan
Medpace Holdings, Inc. 2Q 2026: Revenue $707.33M, EPS $4.25— 10-Q Summary - TradingView
Medpace jumps 15%, order rebound eases fears - marketscreener.com
Medpace Holdings, Inc. Quarterly Earnings Report - Stock Titan
MEDP Stock Jumps On Earnings Beat And Raised 2026 Outlook - StocksToTrade
Medpace Holdings stock hits all-time high at 649.5 USD By Investing.com - Investing.com India
Medpace Soars After Q2 Beat, Strong Backlog Fuels 2026 OutlookMedpace Holdings (NASDAQ:MEDP) - Benzinga
Medpace (MEDP) Sees Significant Price Surge - GuruFocus
Medpace jumps 15% as order rebound eases fears - marketscreener.com
Medpace Holdings stock hits all-time high at 649.5 USD - Investing.com
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medpace Holdings Inc-Aktie (MEDP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Troendle August J. | President & CEO |
Jul 28 '26 |
Sale |
600.01 |
3,510 |
2,106,035 |
638,946 |
| BURWIG SUSAN E | Exec. VP, Operations |
Jul 28 '26 |
Sale |
600.00 |
7,500 |
4,500,000 |
62,984 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):